Nauck and colleagues (1993) showed that GLP-1 infusion normalized elevated fasting glucose levels in T2D patients (via enhanced insulin secretion)
NICE guidelines on obesity management (NG246) do not recommend probiotics as an intervention for weight loss, focusing instead on evidence-based approaches including dietary modification, physical activity, behavioural interventions, and where appropriate, pharmacological treatments or bariatric surgery
Klinic provides support with prior authorization and insurance handling, ensuring seamless access to available treatments
Not everyone is eligible for GLP-1 weight loss medications
Stal S, Brown RH, Higuera S, Hollier LH, Byrd HS, Cutting CB, et al